Cytosorbents Corp (NASDAQ:CTSO)
Cytosorbents Corp has a live Insider Score.
Scored on 7 qualifying trades from 3 insiders in the last 90 days.
Loses money on what it sells.
- Revenue
- $37.2M
- Net income
- -$18.2M
- Net margin
- -48.9%
Not enough balance-sheet detail to judge the debt load.
- Total debt
- $26.3M
- Cash
- $4.4M
Owes more within a year than it holds to pay it.
- Current assets
- $15.7M
- Current liabilities
- $24.0M
- Current ratio
- 0.66
Consumes cash and must keep raising it.
- Operating cash flow
- -$10.3M
- Free cash flow
- -$10.4M
- FCF margin
- -28.0%
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 3.1M
- Share growth (1y)
- 0.3%
- Cash runway
- 5 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
CTSO Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 9.63 M | 8.86 M | 9.23 M | 9.48 M | 9.62 M | 8.73 M |
| Revenue Growth (YoY) | 0.17 % | 1.57 % | 0.91 % | 10.13 % | 8.76 % | -2.92 % |
| Cost of Revenue | 2.58 M | 2.73 M | 2.43 M | 2.82 M | 2.80 M | 2.52 M |
| Gross Profit | 7.05 M | 6.13 M | 6.80 M | 6.67 M | 6.81 M | 6.21 M |
| SG&A Expense | 7.96 M | 8.15 M | 9.44 M | 8.61 M | 9.17 M | 8.43 M |
| R&D Expense | 1.45 M | 1.02 M | 1.24 M | 918.00 K | 1.26 M | 1.66 M |
| Operating Expenses | 9.69 M | 9.17 M | 10.68 M | 9.53 M | 10.43 M | 10.09 M |
| Operating Income | -2.64 M | -3.04 M | -3.88 M | -2.86 M | -3.62 M | -3.89 M |
| Pretax Income | -4.42 M | -5.13 M | -5.50 M | -3.57 M | 1.95 M | -1.48 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | -401.00 K | 0.00 | 0.00 |
| Net Income | -4.42 M | -5.13 M | -5.50 M | -3.17 M | 1.95 M | -1.48 M |
| EPS (Basic) | -1.40 | -1.60 | -1.75 | -1.00 | 0.62 | -0.49 |
| EPS (Diluted) | -1.40 | -1.60 | -1.75 | -1.00 | 0.58 | -0.49 |
| Shares Outstanding | 3.14 M | 3.14 M | 3.14 M | 3.14 M | 3.13 M | 3.04 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.